Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine

Bayraktutan, Hulya; Symonds, Peter; Brentville, Victoria A.; Moloney, Cara; Galley, Charlotte; Bennett, Clare L.; Mata, Alvaro; Durrant, Lindy; Alexander, Cameron; Gurnani, Pratik

Abstract

DNA technology has emerged as a promising route to accelerated manufacture of sequence agnostic vaccines. For activity, DNA vaccines must be protected and delivered to the correct antigen presenting cells. However, the physicochemical properties of the vector must be carefully tuned to enhance interaction with immune cells and generate sufficient immune response for disease protection. In this study, we have engineered a range of polymer-based nanocarriers based on the poly(beta-amino ester) (PBAE) polycation platform to investigate the role that surface poly(ethylene glycol) (PEG) density has on pDNA encapsulation, formulation properties and gene transfectability both in vitro and in vivo. We achieved this by synthesising a non-PEGylated and PEGylated PBAE and produced formulations containing these PBAEs, and mixed polyplexes to tune surface PEG density. All polymers and co-formulations produced small polyplex nanoparticles with almost complete encapsulation of the cargo in all cases. Despite high gene transfection in HEK293T cells, only the fully PEGylated and mixed formulations displayed significantly higher expression of the reporter gene than the negative control in dendritic cells. Further in vivo studies with a bivalent SARS-CoV-2 pDNA vaccine revealed that only the mixed formulation led to strong antigen specific T-cell responses, however this did not translate into the presence of serum antibodies indicating the need for further studies into improving immunisation with polymer delivery systems.

Citation

Bayraktutan, H., Symonds, P., Brentville, V. A., Moloney, C., Galley, C., Bennett, C. L., Mata, A., Durrant, L., Alexander, C., & Gurnani, P. (2024). Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine. Biomaterials, 311, Article 122647. https://doi.org/10.1016/j.biomaterials.2024.122647

• Journal Article Type: Article
• Acceptance Date: May 30, 2024
• Online Publication Date: Jun 5, 2024
• Publication Date: 2024-12
• Deposit Date: Jun 6, 2024
• Publicly Available Date: Jun 17, 2024
• Journal: Biomaterials
• Print ISSN: 0142-9612
• Electronic ISSN: 1878-5905
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 311
• Article Number: 122647
• DOI: https://doi.org/10.1016/j.biomaterials.2024.122647
• Keywords: vaccine, DNA, delivery, nanoparticle, poly(beta-amino) ester, polyplex, COVID-19, SARS-CoV-2
• Public URL: https://nottingham-repository.worktribe.com/output/35730596
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S0142961224001819